wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q57137315-067D8F26-E967-479C-A75C-E75EC6356761
Q57137315-067D8F26-E967-479C-A75C-E75EC6356761
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57137315-067D8F26-E967-479C-A75C-E75EC6356761
Aromatase, aromatase inhibitors, and breast cancer
P2860
Q57137315-067D8F26-E967-479C-A75C-E75EC6356761
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57137315-067D8F26-E967-479C-A75C-E75EC6356761
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4c2a923cb601327d4eb0649554d3ac57bd839f41
P2860
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.